Eva Anette Engelhardt

Eva Anette Engelhardt (senior executive) discloses dealings in Bio-Rad Laboratories, Inc. to SEC (Form 4). The record holds 11 filings, for trades running from 25 July 2025 to 6 September 2026.

The open-market record consists of 1 sale worth €115k, with no purchase. Outside the open market, there are 5 share grants and 5 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

The latest filing, published on 9 September 2026, reports an option exercise in Bio-Rad Laboratories, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.